JP2023090955A5 - - Google Patents

Download PDF

Info

Publication number
JP2023090955A5
JP2023090955A5 JP2023078304A JP2023078304A JP2023090955A5 JP 2023090955 A5 JP2023090955 A5 JP 2023090955A5 JP 2023078304 A JP2023078304 A JP 2023078304A JP 2023078304 A JP2023078304 A JP 2023078304A JP 2023090955 A5 JP2023090955 A5 JP 2023090955A5
Authority
JP
Japan
Prior art keywords
clostridial toxin
amino acid
modified clostridial
modified
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023078304A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023090955A (ja
Filing date
Publication date
Priority claimed from JP2019147451A external-priority patent/JP6867452B2/ja
Application filed filed Critical
Priority to JP2023078304A priority Critical patent/JP2023090955A/ja
Publication of JP2023090955A publication Critical patent/JP2023090955A/ja
Publication of JP2023090955A5 publication Critical patent/JP2023090955A5/ja
Pending legal-status Critical Current

Links

JP2023078304A 2019-08-09 2023-05-11 陽イオン性神経毒 Pending JP2023090955A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023078304A JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019147451A JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒
JP2023078304A JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021063847A Division JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒

Publications (2)

Publication Number Publication Date
JP2023090955A JP2023090955A (ja) 2023-06-29
JP2023090955A5 true JP2023090955A5 (enExample) 2024-03-07

Family

ID=68768346

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019147451A Active JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A Active JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒
JP2023078304A Pending JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019147451A Active JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A Active JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒

Country Status (1)

Country Link
JP (3) JP6867452B2 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039166A1 (en) * 1995-06-06 1996-12-12 Wisconsin Alumni Research Foundation Analogs of botulinum toxin and pharmaceutical compositions of botulinum toxin
US20020127247A1 (en) * 2000-11-17 2002-09-12 Allergen Sales, Inc. Modified clostridial neurotoxins with altered biological persistence
US7172764B2 (en) * 2003-11-17 2007-02-06 Allergan, Inc. Rescue agents for treating botulinum toxin intoxications
SI2528940T1 (sl) * 2010-01-25 2014-07-31 Allergan, Inc. Metode znotrajcelične pretvorbe enoverižnih beljakovin v njihovo dvoverižno obliko

Similar Documents

Publication Publication Date Title
JP2024012421A5 (enExample)
AR132701A2 (es) Neurotoxinas catiónicas
JP2024512397A5 (enExample)
AR108689A1 (es) Neurotoxinas clostridiales quiméricas
JP2005517627A5 (enExample)
JP6467000B2 (ja) 分解性クロストリジウム毒素
RU2017134357A (ru) Сконструированный ботулинический нейротоксин
RU2008140368A (ru) Peg-илированный мутированный токсин clostridium botulinum
EP4289868A1 (en) Modified neurotoxin single-chain polypeptide and use thereof
EP3746463A1 (en) Non-neuronal snare-cleaving botulinum neurotoxins
US20140099294A1 (en) Biotherapy for Pain
WO2009055350A1 (en) Methods of treating chronic neurogenic inflammation using modified clostridial toxins
JP2021514674A5 (enExample)
US20220010294A1 (en) Novel recombinant botulinum neurotoxins with increased duration of effect
CA2855253A1 (en) Modified neurotoxins with poly-glycine and uses thereof
US11952601B2 (en) Recombinant botulinum toxin with increased duration of effect
Blitzer et al. Botulinum neurotoxin for head and neck disorders
EP3405480B1 (en) Novel recombinant clostridial neurotoxins with increased duration of effect
US20190161783A1 (en) Production of activated clostridial neurotoxins
US20210353725A1 (en) Therapeutic and Cosmetic Uses of Botulinum Neurotoxin Serotype E
US20200354706A1 (en) Novel recombinant botulinum toxin with increased duration of effect
RU2025110789A (ru) Клостридиальные нейротоксины, содержащие активирующий сайт расщепления эндосомальной протеазой
RU2021111910A (ru) Терапевтическое и косметическое применение нейротоксина ботулина серотипа e
RU2023125799A (ru) Модифицированные клостридиальные нейротоксины
JP2015527067A (ja) Ｎ末端リシンを包有する組換タンパク質を製造する新規の方法